Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 71, Issue 3, Pages 196-204Publisher
WILEY
DOI: 10.1067/mcp.2002.121371
Keywords
-
Categories
Ask authors/readers for more resources
Objective: Our objective was to evaluate the presence of CYP3A4 gene variants in white individuals with low CYP3A4 enzyme activity. Methods: Persons with extremely low enzyme activity, either in vitro or in vivo, were selected in a panel of 97 healthy subjects. Genetic analyses for CYP3A4 variant alleles present in white subjects, including CYP3A4*1B, CYP3A4*2, CYP3A4*4, CYP3A4*5, CYP3A4*6, CYP3A4*8, CYP3A4*11, CYP3A4*12, and CYP3A4*13, were performed on genomic deoxyribonucleic acid from these subjects by amplification-restriction and sequencing. Results. With the exception of CYP3A4*1B, none of the variant alleles analyzed were present in 30 genes from persons with extremely low enzyme activity. CYP3214*1B was present in the population studied with an allele frequency of 5.5%. Nevertheless, the presence of CYP3A4*1B does not correlate with low enzyme activity, either in vivo or in vitro, in either heterozygosity or homozygosity. CYP3A4*2 was not identified in 290 genes from Spanish persons or in 70 genes from Finnish persons. Conclusions. Although the genetic component of the interindividual variability of CYP3A4 enzyme activity seems to be high, our findings do not support a key role for the variant alleles analyzed on the majority of white persons with low CYP3A4 activity This suggests the occurrence of as yet unknown mutations that affect CYP3A4 or other functionally related genes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available